About us
Products
Distribution
Careers
Investor Relations
News
Cares
Language:
- Italiano
- English

Home » News » Celadrin per Deejay Ten

Celadrin per Deejay Ten

Published: 27 May 2013 11:17

La Deejay TEN si è conclusa con un grande successo!

Eravamo tantissimi…

<< Articolo precedente Next Article >>

Related News

Special 1 year of stock exchange: interview...

One year after PharmaNutra SPA debut listing on the stock exchange, we draw up a first overall assessment...
(Italiano) Speciale 1 anno di Borsa: intervista...

Sorry, this entry is only available in Italian.

Related Products

CardioSiderAL

CardioSideral® is a nutritional supplement that contains Sucrosomial® Iron (Sideral r.m®), vitamin...
DiKappa2

Dikappa2 is a nutritional supplement containing Vitamin K2 and Vitamin D which promotes intestinal calcium...

Pharmanutra PLC is a pharmaceutical company based in Pisa. It was founded in 2003 with the aim of developing nutraceuticals and medical devices. Pharmanutra follows rigorous standards of quality by maintaining a high attention to the raw materials used, unique and exclusive for the whole national territory.

PharmaNutra Spa | Registered office

Via Delle Lenze, 216/b

56122 Pisa

Tel. +39 050 7846500

Fax +39 050 7846524

C.F. / P.Iva / Reg. Impr. 01679440501

Cap.Soc. € 1.123.097,70

I.V. | REA 146259

Privacy policy
Cookie policy
Condizioni generali

NEWSLETTER

Subscribe to the Pharmanutra newsletter and you will be constantly updated on all our activities.

AWARDS

Ai sensi delle Nuove Linee guida del Ministero della Salute del 28/03/2013, relative alla pubblicità sanitaria concernente i dispositivi medici, dispositivi medico-diagnostici in vitro, presidi medico chirurgici e medicinali da banco, si avvisa l'utente che le informazioni ivi contenute sono esclusivamente rivolte agli operatori professionali.

© Copyright - PHARMANUTRA.IT. All Rights Reserved.

© Copyright - PHARMANUTRA.IT

All Rights Reserved.

This site is set to allow the use of all cookies in order to ensure a better navigation. If you continue to browse, you accept our cookies use. Read More